Intraperitoneal coagulation and fibrinolysis during inflammation: In vivo and in vitro observations

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 99-104

  Sitter, T ^a,b   Godde M ^a   Spannagl, M ^a   Fricke, H ^a   Kooistra, T ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; GENISTEIN; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; BLOOD CLOTTING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PERITONITIS; PRIORITY JOURNAL;

EID: 0029955023     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80060-9     Document Type: Conference Paper

References (17)

1. Gervin AS, Puckett CL, Silver D. Serosal hypofibrinolysis. A cause of postoperative adhesions. Am J Surg 1973; 125: 80-87.
2. Whitaker D, Papadimitrou JM, Walters NI. The mesothelium: Its fibrinolytic properties. J Pathol 1982; 136: 291-299.
3. Thompson JN, Paterson-Brown S, HarbourneT, Whawell SA, Kalodiki E, Dudley HF. Reduced human peritoneal plasminogen activating activity: Possible mechanisms of adhesion formation. Br J Surg 1989; 76: 382-384.
4. Vipond MN, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intraabdominal adhesions. Lancet 1990; 335: 1120-1122.
5. Lill H, Spannagl M, Trauner A, et al. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coag Fibrinol 1993; 4: 97-102.
6. Van Hinsbergh V W M, Vermeer M, Koolwijk P. Grimbergen J, Kooistra T. Genistein reduces TNF induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. Blood 1994; 84: 2984-2991.
7. Bradshaw D, Hill CH, Nixon JS, Wilkinson SE. Therapeutic potential of protein kinase C inhibitors. Agents Actions 1993; 38: 135-147.
8. Sitter T, Spannagl M, Schiffl H, Held E, Van Hinsbergh VWM, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 1995; 10: 677-683.
9. Van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-1497.
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
11. Van Zonneveld A, Chang GTG, Van den Berg J et al. Quantification of t-PA mRNA in human endothelial cells cultures by hybridization with a t-PA cDNA probe. Biochem J 1986; 235: 350-390.
12. Van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, Van Hinsbergh VWM. Regulation of PAN 1 mRNA in human endothelial cells. Thromb Haemost 1988; 60: 63-67.
13. Medcalf RL, Van den Berg E, Schleuining WD. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. J Cell Biol 1988; 106: 971-978
14. Van der Logt CPE, Reitsma PH, Bertina RM. Alternative splicing is responsible for the presence of two tissue factor mRNA species in LPS stimulated human monocytes. Thromb Haemost 1992; 67: 272-276.
15. Gries E, Kopp J, Thomae U, Kuhlmann H. Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis. Thromb Heamost 1990; 63: 356-360.
16. Whawell SA, Wang YM, Fleming KA Thompson EM, Thompson IN. Localization of plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA hybridization. J Pathol 1993; 169: 67-71.
17. Niedbala M J, Stein-Picarella MM. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood 1993; 81: 2608-2617.